Czerney Kevin 4

What Happened Kevin Czerney, Vice President and Chief Accounting Officer of DENTSPLY SIRONA (XRAY), received a grant/award of 2,853.551 shares classified as a derivative (phantom stock) on 2026-03-11. The reported per-share value for the award was $11.43, for a total reported value of $32,616. This was reported on a Form 4 filed 2026-03-12. The transaction type is coded A (award/grant).

Key Details

• Transaction date: 2026-03-11; Form 4 filed: 2026-03-12 (timely filing).
• Instrument: Phantom stock (derivative award) — 2,853.551 shares @ $11.43 each; total $32,616.
• Transaction code: A = Award/Grant.
• Shares owned after transaction: Not specified in the filing.
• Notable footnotes:
  • F1: Each phantom share equals the economic equivalent of one common share and becomes payable in common stock upon termination of employment.
  • F2: The award is comprised of phantom stock.
  • F3: This includes a Supplemental Executive Retirement Plan (SERP) contribution for 2025 based on the 12/31/2025 closing price.

Context This was a compensation-related derivative award (phantom stock), not an open-market purchase or sale. Phantom-share grants are typically part of executive compensation and are payable in common stock upon certain conditions (here, termination), so they reflect compensation policy rather than an immediate buy or sell decision.